Cellaviva is Sweden’s first private biobank for Family Saving of stem cells from umbilical cord blood and tissue. Cellaviva has been granted permission to operate by the Health and Social Care Inspectorate (IVO) and is the only private actor with permission to act in Sweden. Cellaviva is the trademark used to market stem cell banking, owned by NextCell Pharma AB. Please visit www.nextcellpharma.com for more info.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for Cellaviva on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.